These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 18046084)
1. Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors. Tonini M; Vigneri S; Neri M; Cuomo R; Savarino V; Pace F Digestion; 2007; 76(3-4):171-8. PubMed ID: 18046084 [TBL] [Abstract][Full Text] [Related]
2. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease. Watson TJ; Peters JH Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131 [TBL] [Abstract][Full Text] [Related]
3. Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs? Bruley des Varannes S; Coron E; Galmiche JP Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):905-21. PubMed ID: 21126703 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system. Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412 [TBL] [Abstract][Full Text] [Related]
5. Treatment of gastroesophageal reflux disease in adults: an individualized approach. Galmiche JP; Stephenson K Dig Dis; 2004; 22(2):148-60. PubMed ID: 15383756 [TBL] [Abstract][Full Text] [Related]
6. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Gralnek IM; Dulai GS; Fennerty MB; Spiegel BM Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1452-8. PubMed ID: 17162239 [TBL] [Abstract][Full Text] [Related]
15. Evolving issues in the management of reflux disease? Yuan Y; Hunt RH Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644 [TBL] [Abstract][Full Text] [Related]
16. Is the use of esomeprazole in gastroesophageal reflux disease a cost-effective option in Poland? Petryszyn P; Staniak A; Grzegrzolka J J Comp Eff Res; 2016 Mar; 5(2):169-78. PubMed ID: 26946951 [TBL] [Abstract][Full Text] [Related]
17. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Freedberg DE; Kim LS; Yang YX Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716 [TBL] [Abstract][Full Text] [Related]